The JDRF Biomarker Working Group (BWG) is a collaborative network of investigators, working individually and collectively to address key questions related to the identification, optimization, and clinical confirmation of T1D biomarkers.
Biomarkers of interest will:
- Predict disease onset
- Predict disease progression
- Stratify patients for therapy
- Serve as surrogate markers for therapeutic efficacy
The focus of the BWG is to facilitate the discovery and validation of biomarkers relevant to T1D via the sharing of reagents, methods, strategies, samples, knowledge, and data.